Entourage’s Post

"Masaki Wakabayashi's rise to President and CEO of GE Healthcare Japan is an incredible journey, marked by a strategic shift from pharmaceuticals to medical devices, driven by his belief in enhancing lives through early and precision diagnosis. His leadership is characterized by authenticity as well as adaptability, steering his organizations with a commitment to excellence. This story delves into the experiences that have defined his leadership approach, underscoring his dedication to cultivating a workplace that values diversity, openness, and innovation." Written by: Karin Jork-Wellbrock (PCC), Senior Level Executive Contributor

Reflecting on a pivotal moment in my career journey: in 2011, freshly minted as a physician, I found myself navigating the transition from academia to industry. It was then that I encountered a transformative figure who would leave an indelible mark on both my professional trajectory and personal growth. Stephane Bentolila was the visionary General Manager of Servier Argentina. Amidst the dynamic landscape of the pharmaceutical industry, he recognized potential in me and extended a guiding hand. His belief in my capabilities not only secured my role as a Marketing leader for the Cardiometabolic Franchise but also ignited a journey of mentorship and empowerment. Throughout my tenure, Stephane's unwavering support served as a beacon, particularly during the initial stages of onboarding when uncertainty loomed large. He encouraged calculated risks, fostering an environment where failure was embraced as a stepping stone to growth. Under his tutelage, I gleaned invaluable insights and honed skills that continue to shape my approach to this day. We met each other this week at the #ESC #HeartFailure Congress (after almost 10 years). It was an opportunity to share my profound gratitude for Stephane's intuition and boldness in championing emerging talent like myself. His willingness to look beyond the conventional pool of candidates speaks volumes about the transformative power of visionary leadership. To fellow leaders, I pose a question: are you entrusting your instincts to unearth untapped potential or adhering to the status quo?

🌐 Embracing a Culture-Centric Approach in Nonprofit Leadership 🌟 The recent piece on Novo Nordisk underscores the power of culture in fostering innovation and driving success. Like Novo Nordisk's commitment to a culture of collaboration and patient-centricity, non-profits can achieve remarkable outcomes by prioritizing values and character. 🚀 In the nonprofit sector, where our mission is to make a positive difference, building a culture that aligns with our core values is crucial. Strategy may guide us, but culture empowers us. The shared beliefs, attitudes, and behaviors define who we are and how we work toward our goals. 💡 Let's reflect on how we can cultivate a culture that amplifies our impact and attracts passionate individuals who resonate with our mission. How do we foster an environment where creativity thrives, and collaboration becomes second nature? 🌱 As leaders, let's lead by example, embodying our values. Our character, demonstrated through our actions, sets the tone for the entire organization. By placing culture at the forefront, we create a resilient foundation that withstands challenges and propels us towards our vision. Read the insightful article here: https://lnkd.in/gDbSt3bC Let's continue the conversation on the importance of culture in driving nonprofit success! Share your thoughts and experiences below. Together, we can shape a future where our impact is not just measured by numbers but by the enduring legacy of our shared values. 🌍💙 #NonprofitLeadership #CultureOverStrategy #MissionDriven #LeadershipMatters

Content so good I should not be giving it out for free (don't tell my boss). Welcome to Part 1 in our "Scrip Asks" article series where we invite industry leaders, investors, experts and other stakeholders to share their expectations for the year ahead. With responses from hundreds of professionals, "Scrip Asks…What Does 2024 Hold For Biopharma?" provides an exceptional insight, both broad and deep, into the biopharma universe’s collective crystal ball. Part 1 is on Business Strategy And Leadership with exclusive insights you won't find anywhere else from: Johnson & Johnson, AbbVie, Genmab, Gilead Sciences to name a few! #biopharma #strategy #innovation

How could companies leverage patient-centricity, talent engagement and technology adoption to deliver not just business results, but also business agility and future-readiness? Catch Sharon Barber-Lui from Teva Pharmaceuticals discuss this and much more with Manish Gupta in our inaugural keynote session of the 5th Indegene Digital Summit!

Mindset Matters! In this thought leadership article, Padraic Ward, Head of Roche Pharma International, is coming back on two big questions we had when we launched our transformation: did we have the right mindset and approach to lead our organisation towards the future we wanted to see? And if not, how did we need to change? Discover how we challenged ourselves to be the leaders that patients need us to be.

“The challenge is, right now, many companies are realizing they have a lot of expensive talent and expertise that is different from what they need going forward, which increases pressure on their ability to respond to the changes in the industry.” Check out more compelling thoughts on current pharma leadership navigation in my Q&A with strategy experts from BTS.

The recent updates from BenevolentAI brings back some echoes of similar hurdles I've encountered. It's a pity to witness a company facing difficulties, but it's also a crucial part of the business journey. Managing tough times effectively is as important as celebrating victories, and it's during these moments that true leadership is tested and forged. Good luck to the BenevolentAI management team! #leadership

📑 👨💻 Personalization, agile content creation, technology adoption, collaboration across functions and with health authorities are key to elevating MLR review processes. That’s what Vincenzo Bartoli (AstraZeneca), Jaime Blais (The Janssen Pharmaceutical Companies of Johnson & Johnson) and Moulakshi Roychowdhury (AbbVie) advised life sciences leaders in this panel discussion with Sameer Lal at Indegene Digital Summit. From relevant content to AI’s impact on MLR and compliance to channel integration, check out their perspectives here.